Yale Cancer Center researchers show adding radiation after immunotherapy improves survival time for patients with advanced lung cancer

The results of a phase II clinical trial by Yale Cancer Center (YCC) researchers show adding high-dose radiation after immunotherapy stops working increases survival time for patients with metastatic non-small-cell lung cancer (NSCLC).

Read more